Keywords: imclone, pay, repligen, 65m, erbitux, case, biopharmaceutical

ImClone to pay Repligen $65M in Erbitux case

Article | 17 September 2007

Print This

Biopharmaceutical firm Repligen has reached a settlement in its law suit against fellow US firm ImClone, which alleged that the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in